EntryPoint Capital »

Crinetics Pharmaceuticals In shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $127k 2.8k 44.79

More positions owned by EntryPoint Capital

Global Ship Lease Com Cl A (GSL)
Delek Us Holdings (DK)
CoStar (CSGP)
Vista Energy S.a.b. De C.v. Sponsored Ads (VIST)
Skechers U S A Cl A (SKX)
Nextera Energy Partners Com Unit Part In (NEP)
Alerus Finl (ALRS)
Liveramp Holdings (RAMP)
Trimas Corp Com New (TRS)
Cbl & Assoc Pptys Common Stock (CBL)
Rockwell Automation (ROK)
Illinois Tool Works (ITW)
National Fuel Gas (NFG)
EastGroup Properties (EGP)
Hologic (HOLX)

View all positions for EntryPoint Capital

Top funds holding Crinetics Pharmaceuticals In

BlackRock
Driehaus Capital Management
Vanguard Group
T. Rowe Price Associates
EcoR1 Capital
State Street Corporation
Jennison Associates
Point72 Asset Management
Paradigm Biocapital Advisors
Henderson Group
Geode Capital Management
Perceptive Advisors
Franklin Resources
Cormorant Asset Management
T. Rowe Price Investment Management

View all funds holding Crinetics Pharmaceuticals In